Michael Jaffe, DO
Physical Medicine & Rehabilitation · Kailua, HINPI 1396893251
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,410 of the $12,360 with a category attached, or 84.2%. 23 manufacturers reported payments, led by Medtronic at 32.0% of the total. Among physical medicine & rehabilitation clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 307 payments — averaging $40.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Abbott$2K
- Boston Scientific$2K
- AbbVie$2K
- Nevro Corp.$605
- Merz Pharmaceuticals, LLC$374
- plus $2K from 17 others
What the payments were for
- Travel & lodging$1,95016%
- Food & beverage$10,41084%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 64 | $3,955 |
| Abbott | 34 | $2,102 |
| Boston Scientific | 93 | $1,698 |
| AbbVie(2 entities) | 51 | $1,637 |
| Nevro Corp. | 17 | $605 |
| Merz Pharmaceuticals, LLC | 6 | $374 |
| Ipsen Biopharmaceuticals, Inc | 9 | $275 |
| Vertex | 3 | $256 |
| MML US, Inc. | 2 | $222 |
| Amgen | 3 | $164 |
| Biotronik NRO, Inc. | 5 | $164 |
| Merz North America, Inc. | 3 | $149 |
| Relievant Medsystems, Inc. | 1 | $136 |
| Teva Pharmaceuticals USA, Inc. | 1 | $114 |
| SPR Therapeutics, Inc | 1 | $93 |
| Pacira Pharmaceuticals Incorporated | 2 | $88 |
| Pfizer | 4 | $84 |
| Pacira Therapeutics, Inc. | 1 | $80 |
| Vanda Pharmaceuticals Inc. | 2 | $67 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Livanova USA, Inc. | 1 | $27 |
| Avanos Medical | 1 | $20 |
| Stryker | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$1,973
- PROCLAIM$618
- GENERAL PAIN MANAGEMENT$494
- Proclaim Family of SCS IPGs$436
- XEOMIN$344
- Intracept$272
- UBRELVY$250
- ETERNA$208
- INTELLIS$193
- ReActiv8$176
- SYNCHROMED$175
- WaveWriter Alpha Prime 16$164
- INTELLIS ADAPTIVESTIM$145
- Proclaim IPG$138
- Senza$134
- Omnia$128
- BOTOX$125
- QULIPTA$125
- JOURNAVX$122
- EVENITY$119
How this compares
$12,360 in reported general payments places this provider in the 95th percentile of 32 physical medicine & rehabilitation providers in Hawaii.
See all physical medicine & rehabilitation providers in Hawaii →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BotoxOnabotulinumtoxina | 12 | $21,010 |
| OxycontinOxycodone Hcl | 14 | $10,806 |
| Duloxetine Hcl | 144 | $4,528 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 32 | $4,211 |
| Cyclobenzaprine Hcl | 49 | $3,068 |
| Oxycodone Hcl | 183 | $2,917 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 120 | $2,586 |
| Celecoxib | 34 | $2,489 |
| Baclofen | 91 | $1,679 |
| Gabapentin | 78 | $1,557 |
| Pregabalin | 33 | $1,278 |
| Tizanidine Hcl | 50 | $1,247 |
| Meloxicam | 34 | $699 |
| Nortriptyline Hcl | 30 | $651 |
| Morphine Sulfate | 17 | $630 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieBotox | $1,637 | $21,01012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 32 physical medicine & rehabilitation providers in Hawaii.
Other physical medicine & rehabilitation in Kailua
- Kristiana LazarovaKailua$34
- Michael YamazakiHonolulu$15K
- Anthony LeungHonolulu$6K
- Bruce KatsuraHonolulu$4K
- Jason ChangHonolulu$2K
- Kaipo PauHonolulu$2K
- Linda RowanHonolulu$1K
- Jayson TakataHonolulu$1K
- Gilbert HagerKapolei$1K
- Andrew MontemayorHonolulu$597
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.